Page:United States Statutes at Large Volume 124.djvu/492

This page needs to be proofread.

124 STAT. 466 PUBLIC LAW 111–148—MAR. 23, 2010 ‘‘(i) the amount that the manufacturer would have paid with respect to such discounts under the agree- ment, which will then be used to pay the discounts which the manufacturer had failed to provide; and ‘‘(ii) 25 percent of such amount. ‘‘(B) APPLICATION.—The provisions of section 1128A (other than subsections (a) and (b)) shall apply to a civil money penalty under this paragraph in the same manner as such provisions apply to a penalty or proceeding under section 1128A(a). ‘‘(f) CLARIFICATION REGARDING AVAILABILITY OF OTHER COV- ERED PART D DRUGS.—Nothing in this section shall prevent an applicable beneficiary from purchasing a covered part D drug that is not an applicable drug (including a generic drug or a drug that is not on the formulary of the prescription drug plan or MA– PD plan that the applicable beneficiary is enrolled in). ‘‘(g) DEFINITIONS.—In this section: ‘‘(1) APPLICABLE BENEFICIARY.—The term ‘applicable bene- ficiary’ means an individual who, on the date of dispensing an applicable drug— ‘‘(A) is enrolled in a prescription drug plan or an MA– PD plan; ‘‘(B) is not enrolled in a qualified retiree prescription drug plan; ‘‘(C) is not entitled to an income-related subsidy under section 1860D–14(a); ‘‘(D) is not subject to a reduction in premium subsidy under section 1839(i); and ‘‘(E) who— ‘‘(i) has reached or exceeded the initial coverage limit under section 1860D–2(b)(3) during the year; and ‘‘(ii) has not incurred costs for covered part D drugs in the year equal to the annual out-of-pocket threshold specified in section 1860D–2(b)(4)(B). ‘‘(2) APPLICABLE DRUG.—The term ‘applicable drug’ means, with respect to an applicable beneficiary, a covered part D drug— ‘‘(A) approved under a new drug application under section 505(b) of the Federal Food, Drug, and Cosmetic Act or, in the case of a biologic product, licensed under section 351 of the Public Health Service Act (other than a product licensed under subsection (k) of such section 351); and ‘‘(B)(i) if the PDP sponsor of the prescription drug plan or the MA organization offering the MA–PD plan uses a formulary, which is on the formulary of the prescrip- tion drug plan or MA–PD plan that the applicable bene- ficiary is enrolled in; ‘‘(ii) if the PDP sponsor of the prescription drug plan or the MA organization offering the MA–PD plan does not use a formulary, for which benefits are available under the prescription drug plan or MA–PD plan that the applicable beneficiary is enrolled in; or ‘‘(iii) is provided through an exception or appeal. ‘‘(3) APPLICABLE NUMBER OF CALENDAR DAYS.—The term ‘applicable number of calendar days’ means—